Pasar al contenido principal

ESTUDIO Y BLOQUEO DE LAS INTERACCIONES DE LAS CELULAS CANCEROSAS DE GLIOBLASTOMA CON EL MICROAMBIENTE PARA MEJORES ENFOQUES TERAPEUTICOS COMBINATORIOS

PID2022-137672NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis

  • Cantó-Santos, Judith|||0000-0002-0272-7014
  • Valls-Roca, Laura|||0000-0001-5956-6752
  • Tobías, Ester|||0000-0002-9968-3651
  • García García, Francesc Josep|||0000-0001-9021-0324
  • Guitart-Mampel, Mariona
  • Andújar-Sánchez, Félix
  • Vilaseca-Capel, Adrià
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Martín-Mur, Beatriz|||0000-0002-6006-3295
  • Padrosa, Joan
  • Peruga, Emma
  • Madrigal, Irene|||0000-0002-7229-1199
  • Segalés, Paula
  • García-Ruiz, Carmen
  • Fernández-Checa, José Carlos
  • Moreno-Lozano, Pedro J.
  • Selva O'Callaghan, Albert|||0000-0003-2823-9761
  • Sevilla, Ana|||0000-0002-9251-4759
  • Milisenda, José César|||0000-0003-0151-7872
  • Garrabou, Glòria|||0000-0001-8973-9933
Inclusion body myositis (IBM) is an inflammatory myopathy that displays proximal and distal muscle weakness. At the histopathological level, the muscles of IBM patients show inflammatory infiltrates, rimmed vacuoles and mitochondrial changes. The etiology of IBM remains unknown, and there is a lack of validated disease models, biomarkers and effective treatments. To contribute to unveil disease underpins we developed a cell model based on myotubes derived from induced pluripotent stem cells (iPSC-myotubes) from IBM patients and compared the molecular phenotype vs. age and sex-paired controls (n = 3 IBM and 4 CTL). We evaluated protein histological findings and the gene expression profile by mRNA-seq, alongside functional analysis of inflammation, degeneration and mitochondrial function. Briefly, IBM iPSC-myotubes replicated relevant muscle histopathology features of IBM, including aberrant expression of HLA, TDP-43 and COX markers. mRNA seq analysis identified 1007 differentially expressed genes (DEGs) (p-value adj < 0.01; 789 upregulated and 218 downregulated), associated with myopathy, muscle structure and developmental changes. Among these, 1 DEG was related to inflammation, 28 to autophagy and 28 to mitochondria. At the functional level, inflammation was similar between the IBM and CTL groups under basal conditions (mean cytokine expression in IBM 4.6 ± 1.4 vs. 6.7 ± 3.4 in CTL), but increased in IBM iPSC-myotubes after lipopolysaccharide treatment (72.5 ± 21.8 in IBM vs. 13.0 ± 6.7 in CTL). Additionally, autophagy was disturbed, with 40.14% reduction in autophagy mediators. Mitochondrial dysfunction was strongly manifested, showing a conserved respiratory profile and antioxidant capacity, but a 56.33% lower cytochrome c oxidase/citrate synthase ratio and a 66.59% increase in lactate secretion. Overall, these findings support patient-derived iPSC-myotubes as a relevant model for IBM, reflecting the main muscle hallmarks, including inflammation, autophagy dysfunction and mitochondrial alterations at transcriptomic, protein and functional levels.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis

  • Cantó-Santos, Judith
  • Valls-Roca, Laura
  • Tobías, Ester
  • García-García, Francesc Josep
  • Guitart-Mampel, Mariona
  • Andújar-Sánchez, Félix
  • Vilaseca-Capel, Adrià
  • Esteve-Codina, Anna
  • Martín-Mur, Beatriz
  • Padrosa, Joan
  • Peruga, Emma
  • Madrigal, Irene
  • Segalés, Paula
  • García-Ruiz, Carmen
  • Fernández-Checa, José C.
  • Moreno-Lozano, Pedro J.
  • Selva O'Callaghan, Albert
  • Sevilla, Ana
  • Milisenda, José César
  • Garrabou, Glòria
Inclusion body myositis (IBM) is an inflammatory myopathy that displays proximal and distal muscle weakness. At the histopathological level, the muscles of IBM patients show inflammatory infiltrates, rimmed vacuoles and mitochondrial changes. The etiology of IBM remains unknown, and there is a lack of validated disease models, biomarkers and effective treatments. To contribute to unveil disease underpins we developed a cell model based on myotubes derived from induced pluripotent stem cells (iPSC-myotubes) from IBM patients and compared the molecular phenotype vs. age and sex-paired controls (n = 3 IBM and 4 CTL). We evaluated protein histological findings and the gene expression profile by mRNA-seq, alongside functional analysis of inflammation, degeneration and mitochondrial function. Briefly, IBM iPSC-myotubes replicated relevant muscle histopathology features of IBM, including aberrant expression of HLA, TDP-43 and COX markers. mRNA seq analysis identified 1007 differentially expressed genes (DEGs) (p-value adj < 0.01; 789 upregulated and 218 downregulated), associated with myopathy, muscle structure and developmental changes. Among these, 1 DEG was related to inflammation, 28 to autophagy and 28 to mitochondria. At the functional level, inflammation was similar between the IBM and CTL groups under basal conditions (mean cytokine expression in IBM 4.6 ± 1.4 vs. 6.7 ± 3.4 in CTL), but increased in IBM iPSC-myotubes after lipopolysaccharide treatment (72.5 ± 21.8 in IBM vs. 13.0 ± 6.7 in CTL). Additionally, autophagy was disturbed, with 40.14% reduction in autophagy mediators. Mitochondrial dysfunction was strongly manifested, showing a conserved respiratory profile and antioxidant capacity, but a 56.33% lower cytochrome c oxidase/citrate synthase ratio and a 66.59% increase in lactate secretion. Overall, these findings support patient-derived iPSC-myotubes as a relevant model for IBM, reflecting the main muscle hallmarks, including inflammation, autophagy dysfunction and mitochondrial alterations at transcriptomic, protein and functional levels., This study was supported by Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III (ISCIII) (Grant code PI21/00935 and PI24/00428), El Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), initiatives of ISCIII and FEDER. Additionally, MG-M is supported by CD21/00019 (ISCIII-FSE+), LV-R is supported by FI22/00142 (ISCIII-NextGenerationEU) and A.S. by the grant PID2022-137672NB-I00 funded by MCIN/AEI/https://doi.org/10.13039/501100011033 and by the ERDF A way of making Europe, the grant PDC 2022-133826-100 funded by MCIN/AEI/https://doi.org/10.13039/501100011033 and by the European Union Next Generation EU/PRTR, the grant CNS2023-144709 funded by MCIN/AEI/https://doi.org/10.13039/501100011033 and by the European Union Next Generation EU/PRTR and the Catalan Government (2021SGR00453 and 2021-SGR-01423)., Peer reviewed